OR WAIT null SECS
August 15, 2022
Pharma loses battle to block price negotiations, but implementation faces many challenges.
August 08, 2022
Newly unveiled workplan focuses on harnessing the impact of big data on drug development—and ultimately public health.
August 04, 2022
Better clinical data needed, as well as strategies for tackling opioid abuse, tobacco use, and food safety.
August 02, 2022
Recent updates from regulatory bodies are providing more confidence in integrating different forms of trials and technology.
August 01, 2022
Citing strong reporting results, hybrid model to continue supplementing on-site inspections.
July 26, 2022
The scope of RWE’s use in developing and approving new medicines is pitting key healthcare stakeholders against each other.
With debate swirling around products cleared through this pathway, reforms and tighter oversight likely.
July 18, 2022
With the renewal deadline looming—and disagreement still swirling on enhancing FDA authority—a counter proposal calls for a streamlined, fee-only bill.
Payers join the push for better demonstrations of efficacy of new medicines.
July 13, 2022
Why oncology needs dosing redesign.